Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide carries a boxed warning about thyroid C-cell tumors observed in rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Moving too quickly to high doses wastes product if you respond well to lower amounts, and offers no additional safety buffer if issues arise
Nothing here is a recommendation for human use
11.8% average weight loss as monotherapy in Phase 3 trialsclinically significant and comparable to first-generation GLP-1 medications
Though there is no data correlating the following side effects specifically to Selank, some anecdotal reports report the following reactions following administration: Headaches Pain/redness at the injection site Sinus irritation following nasal administration Sore throat Nausea While Selank appears to be safe according to the available evidence, researchers must perform due diligence before commencing research on the peptide
US$ 20.87
US$ 29.88
US$ 28.31
US$ 25.67
US$ 27.94
US$ 26.01